1. Home
  2. PRPO vs MFI Comparison

PRPO vs MFI Comparison

Compare PRPO & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • MFI
  • Stock Information
  • Founded
  • PRPO N/A
  • MFI 2002
  • Country
  • PRPO United States
  • MFI Hong Kong
  • Employees
  • PRPO N/A
  • MFI N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • MFI
  • Sector
  • PRPO Industrials
  • MFI
  • Exchange
  • PRPO Nasdaq
  • MFI NYSE
  • Market Cap
  • PRPO 9.9M
  • MFI 9.9M
  • IPO Year
  • PRPO N/A
  • MFI 2024
  • Fundamental
  • Price
  • PRPO $6.90
  • MFI $0.71
  • Analyst Decision
  • PRPO
  • MFI
  • Analyst Count
  • PRPO 0
  • MFI 0
  • Target Price
  • PRPO N/A
  • MFI N/A
  • AVG Volume (30 Days)
  • PRPO 6.7K
  • MFI 334.1K
  • Earning Date
  • PRPO 03-28-2025
  • MFI 02-19-2025
  • Dividend Yield
  • PRPO N/A
  • MFI N/A
  • EPS Growth
  • PRPO N/A
  • MFI N/A
  • EPS
  • PRPO N/A
  • MFI N/A
  • Revenue
  • PRPO $17,411,000.00
  • MFI $3,877,747.00
  • Revenue This Year
  • PRPO $75.18
  • MFI N/A
  • Revenue Next Year
  • PRPO N/A
  • MFI N/A
  • P/E Ratio
  • PRPO N/A
  • MFI N/A
  • Revenue Growth
  • PRPO 31.31
  • MFI N/A
  • 52 Week Low
  • PRPO $4.31
  • MFI $0.51
  • 52 Week High
  • PRPO $7.20
  • MFI $14.49
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 63.80
  • MFI N/A
  • Support Level
  • PRPO $6.52
  • MFI N/A
  • Resistance Level
  • PRPO $6.90
  • MFI N/A
  • Average True Range (ATR)
  • PRPO 0.27
  • MFI 0.00
  • MACD
  • PRPO 0.03
  • MFI 0.00
  • Stochastic Oscillator
  • PRPO 89.90
  • MFI 0.00

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: